期刊
BMC PHARMACOLOGY & TOXICOLOGY
卷 18, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s40360-017-0118-9
关键词
Lung cancer cell; Drug resistance; Side population; Voltage-gated potassium channel; Combination therapy
资金
- Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012-R1A2A2A01047151, NRF-2014R1A1A3A04052757]
- Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning [2016M3A9B6026771]
Background: Side-population (SP) cells that exclude anti-cancer drugs have been found in various tumor cell lines. Moreover, SP cells have a higher proliferative potential and drug resistance than main population cells (Non-SP cells). Also, several ion channels are responsible for the drug resistance and proliferation of SP cells in cancer. Methods: To confirm the expression and function of voltage-gated potassium (Kv) channels of SP cells, these cells, as well as highly expressed ATP-binding cassette (ABC) transporters and stemness genes, were isolated from a gefitinib-resistant human lung adenocarcinoma cell line (NCI-H460), using Hoechst 33342 efflux. Results: In the present study, we found that mRNA expression of Kv channels in SP cells was different compared to Non-SP cells, and the resistance of SP cells to gefitinib was weakened with a combination treatment of gefitinib and Kv channel blockers or a Kv7 opener, compared to single-treatment gefitinib, through inhibition of the Ras-Raf signaling pathway. Conclusions: The findings indicate that Kv channels in SP cells could be new targets for reducing the resistance to gefitinib.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据